
In addition to a significant PFS benefit vs nab-paclitaxel alone, the combination provides an at-home option for patients with ovarian cancer.
Alexander Olawaiye, MD, is a professor of gynecologic oncology at the University of Pittsburgh, and Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania.